{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T06:26:28Z","timestamp":1783837588238,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s15010-024-02432-5","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T12:31:05Z","timestamp":1731069065000},"page":"635-647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vivo divergent evolution of cross-resistance to new \u03b2-lactam\/\u03b2-lactamase inhibitor combinations in Pseudomonas aeruginosa following ceftazidime\/avibactam treatment"],"prefix":"10.1007","volume":"53","author":[{"given":"Heng","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanming","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piaopiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"issue":"1","key":"2432_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/22221751.2022.2048972","volume":"11","author":"FC Tenover","year":"2022","unstructured":"Tenover FC, Nicolau DP, Gill CM. Carbapenemase-producing - an emerging challenge. Emerg Microbes Infec. 2022;11(1):811\u20134. https:\/\/doi.org\/10.1080\/22221751.2022.2048972.","journal-title":"Emerg Microbes Infec"},{"issue":"3","key":"2432_CR2","doi-asserted-by":"publisher","first-page":"E159","DOI":"10.1016\/S2666-5247(22)00329-9","volume":"4","author":"J Reyes","year":"2023","unstructured":"Reyes J, Komarow L, Chen L, Ge LZ, Hanson BM, Cober E, et al. Global epidemiology and clinical outcomes of carbapenem-resistant and associated carbapenemases (POP): a prospective cohort study. Lancet Microbe. 2023;4(3):E159\u201370. https:\/\/doi.org\/10.1016\/S2666-5247(22)00329-9.","journal-title":"Lancet Microbe"},{"key":"2432_CR3","doi-asserted-by":"publisher","unstructured":"Horcajada JP, Montero M, Oliver A, Sorl\u00ed L, Luque S, G\u00f3mez-Zorrilla S et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant infections. Clin Microbiol Rev. 2019;32(4):e00031-19. https:\/\/doi.org\/10.1128\/CMR.00031-19.","DOI":"10.1128\/CMR.00031-19"},{"key":"2432_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drup.2019.07.002","volume":"44","author":"J Botelho","year":"2019","unstructured":"Botelho J, Grosso F, Peixe L. Antibiotic resistance in - mechanisms, epidemiology and evolution. Drug Resist Update. 2019;44:26\u201347. https:\/\/doi.org\/10.1016\/j.drup.2019.07.002.","journal-title":"Drug Resist Update"},{"issue":"2","key":"2432_CR5","doi-asserted-by":"publisher","first-page":"e0200021","DOI":"10.1128\/AAC.02000-21","volume":"66","author":"YL Lee","year":"2022","unstructured":"Lee YL, Ko WC, Hsueh PR. Geographic patterns of carbapenem-resistant Pseudomonas aeruginosa in the asia-pacific region: results from the antimicrobial testing leadership and surveillance (ATLAS) program, 2015\u20132019. Antimicrob Agents Chemother. 2022;66(2):e0200021. https:\/\/doi.org\/10.1128\/AAC.02000-21.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2432_CR6","doi-asserted-by":"publisher","first-page":"e0169722","DOI":"10.1128\/spectrum.01697-22","volume":"10","author":"C Weber","year":"2022","unstructured":"Weber C, Schultze T, Gottig S, Kessel J, Schroder A, Tietgen M, et al. Antimicrobial activity of ceftolozane-tazobactam, ceftazidime-avibactam, and cefiderocol against multidrug-resistant Pseudomonas aeruginosa recovered at a German University Hospital. Microbiol Spectr. 2022;10(5):e0169722. https:\/\/doi.org\/10.1128\/spectrum.01697-22.","journal-title":"Microbiol Spectr"},{"issue":"5","key":"2432_CR7","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/jac\/dkad062","volume":"78","author":"I Alonso-Garc\u00eda","year":"2023","unstructured":"Alonso-Garc\u00eda I, V\u00e1zquez-Ucha JC, Lasarte-Monterrubio C, Gonz\u00e1lez-Mayo E, Lada-Salvador P, Vela-Fern\u00e1ndez R, et al. Simultaneous and divergent evolution of resistance to cephalosporin\/\u03b2-lactamase inhibitor combinations and imipenem\/relebactam following ceftazidime\/avibactam treatment of MDR Pseudomonas aeruginosa infections. J Antimicrob Chemoth. 2023;78(5):1195\u2013200. https:\/\/doi.org\/10.1093\/jac\/dkad062.","journal-title":"J Antimicrob Chemoth"},{"key":"2432_CR8","doi-asserted-by":"publisher","unstructured":"Yahav D, Giske CG, Gr\u0101matniece A, Abodakpi H, Tam VH, Leibovici L. New \u03b2-Lactam\u2013\u03b2-Lactamase inhibitor combinations. Clin Microbiol Rev. 2020;34(1). https:\/\/doi.org\/10.1128\/cmr.00115-20.","DOI":"10.1128\/cmr.00115-20"},{"issue":"1","key":"2432_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/jac\/dkaa396","volume":"76","author":"J Arca-Su\u00e1rez","year":"2021","unstructured":"Arca-Su\u00e1rez J, Lasarte-Monterrubio C, Rodi\u00f1o-Janeiro B-K, Cabot G, V\u00e1zquez-Ucha JC, Rodr\u00edguez-Iglesias M, et al. Molecular mechanisms driving thein vivodevelopment of OXA-10-mediated resistance to ceftolozane\/tazobactam and ceftazidime\/avibactam during treatment of XDRPseudomonas aeruginosainfections. J Antimicrob Chemoth. 2021;76(1):91\u2013100. https:\/\/doi.org\/10.1093\/jac\/dkaa396.","journal-title":"J Antimicrob Chemoth"},{"issue":"4","key":"2432_CR10","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1016\/j.jinf.2022.07.011","volume":"85","author":"P Zhang","year":"2022","unstructured":"Zhang P, Wang J, Li Y, Shi W, Cai H, Yang Q, et al. Emergence of blaKPC-33-harboring Hypervirulent ST463 Pseudomonas aeruginosa Causing Fatal infections in China. J Infect. 2022;85(4):e86\u20138. https:\/\/doi.org\/10.1016\/j.jinf.2022.07.011.","journal-title":"J Infect"},{"issue":"3","key":"2432_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cmi.2022.10.013","volume":"29","author":"Q Yang","year":"2023","unstructured":"Yang Q, Li Y, Fang L, Lei T, Cai H, Hua X, et al. A novel KPC-113 variant conferring carbapenem and ceftazidime-avibactam resistance in a multidrug-resistant Pseudomonas aeruginosa isolate. Clin Microbiol Infect. 2023;29(3):387. https:\/\/doi.org\/10.1016\/j.cmi.2022.10.013. e7- e14.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"2432_CR12","doi-asserted-by":"publisher","first-page":"e0078721","DOI":"10.1128\/mSystems.00787-21","volume":"6","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Chen J, Shen H, Chen Z, Yang QW, Zhu J, et al. Emergence of Ceftazidime- and avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Pseudomonas aeruginosa in China. Msystems. 2021;6(6):e0078721. https:\/\/doi.org\/10.1128\/mSystems.00787-21.","journal-title":"Msystems"},{"key":"2432_CR13","doi-asserted-by":"publisher","first-page":"100973","DOI":"10.1016\/j.drup.2023.100973","volume":"69","author":"X Li","year":"2023","unstructured":"Li X, Zhang X, Cai H, Zhu Y, Ji J, Qu T, et al. Overexpression of bla(GES-1) due to a strong promoter in the class 1 integron contributes to decreased ceftazidime-avibactam susceptibility in carbapenem-resistant Pseudomonas aeruginosa ST235. Drug Resist Updat. 2023;69:100973. https:\/\/doi.org\/10.1016\/j.drup.2023.100973.","journal-title":"Drug Resist Updat"},{"key":"2432_CR14","doi-asserted-by":"publisher","unstructured":"Fraile-Ribot PA, Zamorano L, Orellana R, Del Barrio-Tofino E, Sanchez-Diener I, Cortes-Lara S, et al. Activity of imipenem-relebactam against a large collection of Pseudomonas aeruginosa clinical isolates and isogenic beta-lactam-resistant mutants. Antimicrob Agents Chemother. 2020;64(2). https:\/\/doi.org\/10.1128\/AAC.02165-19.","DOI":"10.1128\/AAC.02165-19"},{"issue":"9","key":"2432_CR15","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1093\/jac\/dkaa206","volume":"75","author":"MA Gomis-Font","year":"2020","unstructured":"Gomis-Font MA, Cabot G, Sanchez-Diener I, Fraile-Ribot PA, Juan C, Moya B, et al. In vitro dynamics and mechanisms of resistance development to imipenem and imipenem\/relebactam in Pseudomonas aeruginosa. J Antimicrob Chemother. 2020;75(9):2508\u201315. https:\/\/doi.org\/10.1093\/jac\/dkaa206.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2432_CR16","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/jac\/dkab496","volume":"77","author":"MA Gomis-Font","year":"2022","unstructured":"Gomis-Font MA, Cabot G, Lopez-Arguello S, Zamorano L, Juan C, Moya B, et al. Comparative analysis of in vitro dynamics and mechanisms of ceftolozane\/tazobactam and imipenem\/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones. J Antimicrob Chemother. 2022;77(4):957\u201368. https:\/\/doi.org\/10.1093\/jac\/dkab496.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"2432_CR17","doi-asserted-by":"publisher","first-page":"e0067523","DOI":"10.1128\/aac.00675-23","volume":"67","author":"Y Li","year":"2023","unstructured":"Li Y, Fang L, Dong M, Cai H, Hua X, Jiang Y, et al. Bla (KPC-2) overexpression and bla (GES-5) carriage as major imipenem\/relebactam resistance mechanisms in Pseudomonas aeruginosa high-risk clones ST463 and ST235, respectively, in China. Antimicrob Agents Chemother. 2023;67(11):e0067523. https:\/\/doi.org\/10.1128\/aac.00675-23.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2432_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/cid\/ciac097","volume":"75","author":"RK Shields","year":"2022","unstructured":"Shields RK, Stellfox ME, Kline EG, Samanta P, Van Tyne D. Evolution of Imipenem-Relebactam Resistance following treatment of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia. Clin Infect Dis. 2022;75(4):710\u20134. https:\/\/doi.org\/10.1093\/cid\/ciac097.","journal-title":"Clin Infect Dis"},{"key":"2432_CR19","doi-asserted-by":"publisher","first-page":"674974","DOI":"10.3389\/fmicb.2021.674974","volume":"12","author":"H Cai","year":"2021","unstructured":"Cai H, Zhu Y, Hu D, Li Y, Leptihn S, Loh B, et al. Co-harboring of Novel Bla (KPC-2) plasmid and integrative and conjugative element carrying Tn6203 in Multidrug-Resistant Pseudomonas aeruginosa. Front Microbiol. 2021;12:674974. https:\/\/doi.org\/10.3389\/fmicb.2021.674974.","journal-title":"Front Microbiol"},{"key":"2432_CR20","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. 34th ed; 2024."},{"key":"2432_CR21","doi-asserted-by":"publisher","unstructured":"Wick RR, Judd LM, Gorrie CL, Holt KE, Unicycler. Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13(6):e1005595. https:\/\/doi.org\/10.1371\/journal.pcbi.1005595.","DOI":"10.1371\/journal.pcbi.1005595"},{"issue":"14","key":"2432_CR22","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","volume":"30","author":"T Seemann","year":"2014","unstructured":"Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btu153.","journal-title":"Bioinformatics"},{"key":"2432_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4939-0554-6_12","volume":"1151","author":"DE Deatherage","year":"2014","unstructured":"Deatherage DE, Barrick JE. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol Biol. 2014;1151:165\u201388. https:\/\/doi.org\/10.1007\/978-1-4939-0554-6_12.","journal-title":"Methods Mol Biol"},{"issue":"W1","key":"2432_CR24","doi-asserted-by":"publisher","first-page":"W293","DOI":"10.1093\/nar\/gkab301","volume":"49","author":"I Letunic","year":"2021","unstructured":"Letunic I, Bork P. Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49(W1):W293\u20136. https:\/\/doi.org\/10.1093\/nar\/gkab301.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2432_CR25","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.cmi.2021.11.012","volume":"28","author":"Y Li","year":"2022","unstructured":"Li Y, Zhu Y, Zhou W, Chen Z, Moran RA, Ke H, et al. Alcaligenes faecalis metallo-beta-lactamase in extensively drug-resistant Pseudomonas aeruginosa isolates. Clin Microbiol Infect. 2022;28(6):880. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.012. e1- e8.","journal-title":"Clin Microbiol Infect"},{"key":"2432_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.isci.2018.07.024","volume":"6","author":"W Chen","year":"2018","unstructured":"Chen W, Zhang Y, Zhang Y, Pi Y, Gu T, Song L, et al. CRISPR\/Cas9-based Genome Editing in Pseudomonas aeruginosa and cytidine deaminase-mediated base editing in Pseudomonas species. Iscience. 2018;6:222\u201331. https:\/\/doi.org\/10.1016\/j.isci.2018.07.024.","journal-title":"Iscience"},{"issue":"10","key":"2432_CR27","doi-asserted-by":"publisher","first-page":"e0165019","DOI":"10.1371\/journal.pone.0165019","volume":"11","author":"L Fang","year":"2016","unstructured":"Fang L, Chen Q, Shi K, Li X, Shi Q, He F, et al. Step-wise increase in Tigecycline Resistance in Klebsiella pneumoniae Associated with mutations in ramR, lon and rpsJ. PLoS ONE. 2016;11(10):e0165019. https:\/\/doi.org\/10.1371\/journal.pone.0165019.","journal-title":"PLoS ONE"},{"issue":"9","key":"2432_CR28","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1128\/AAC.40.9.2021","volume":"40","author":"K Poole","year":"1996","unstructured":"Poole K, Tetro K, Zhao Q, Neshat S, Heinrichs DE, Bianco N. Expression of the multidrug resistance operon mexa-mexb-oprm in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob Agents Chemother. 1996;40(9):2021\u20138. https:\/\/doi.org\/10.1128\/AAC.40.9.2021.","journal-title":"Antimicrob Agents Chemother"},{"key":"2432_CR29","doi-asserted-by":"publisher","unstructured":"Torrens G, Hernandez SB, Ayala JA, Moya B, Juan C, Cava F, et al. Regulation of AmpC-driven beta-lactam resistance in Pseudomonas aeruginosa: different pathways, different signaling. Msystems. 2019;4(6). https:\/\/doi.org\/10.1128\/mSystems.00524-19.","DOI":"10.1128\/mSystems.00524-19"},{"issue":"1","key":"2432_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12866-016-0853-x","volume":"16","author":"CG Aguilera Rossi","year":"2016","unstructured":"Aguilera Rossi CG, Gomez-Puertas P, Ayala Serrano JA. In vivo functional and molecular characterization of the penicillin-binding protein 4 (DacB) of Pseudomonas aeruginosa. BMC Microbiol. 2016;16(1):234. https:\/\/doi.org\/10.1186\/s12866-016-0853-x.","journal-title":"BMC Microbiol"},{"issue":"7","key":"2432_CR31","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1128\/AAC.05150-14","volume":"59","author":"A Ropy","year":"2015","unstructured":"Ropy A, Cabot G, Sanchez-Diener I, Aguilera C, Moya B, Ayala JA, et al. Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, beta-lactam resistance, and peptidoglycan structure. Antimicrob Agents Chemother. 2015;59(7):3925\u201334. https:\/\/doi.org\/10.1128\/AAC.05150-14.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"2432_CR32","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1128\/AAC.00257-10","volume":"54","author":"C Alvarez-Ortega","year":"2010","unstructured":"Alvarez-Ortega C, Wiegand I, Olivares J, Hancock RE, Martinez JL. Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Antimicrob Agents Chemother. 2010;54(10):4159\u201367. https:\/\/doi.org\/10.1128\/AAC.00257-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"2432_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2019.05.002","author":"H Qiu","year":"2019","unstructured":"Qiu H, Li Y, Dai W. Codon-usage frequency mediated SNPs selection in lasR gene of cystic fibrosis Pseudomonas aeruginosa isolates. Microbiol Res. 2019. https:\/\/doi.org\/10.1016\/j.micres.2019.05.002. 223\u2013225:137\u2013\u200943.","journal-title":"Microbiol Res"},{"issue":"3","key":"2432_CR34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327. https:\/\/doi.org\/10.1016\/S1473-3099(17)30753-3.","journal-title":"Lancet Infect Dis"},{"key":"2432_CR35","doi-asserted-by":"publisher","unstructured":"Sanz-Garcia F, Hernando-Amado S, Martinez JL. Mutation-driven evolution of Pseudomonas aeruginosa in the presence of either ceftazidime or ceftazidime-avibactam. Antimicrob Agents Chemother. 2018;62(10). https:\/\/doi.org\/10.1128\/AAC.01379-18.","DOI":"10.1128\/AAC.01379-18"},{"issue":"2","key":"2432_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1574-6968.2008.01126.x","volume":"282","author":"H Mammeri","year":"2008","unstructured":"Mammeri H, Nordmann P, Berkani A, Eb F. Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli. FEMS Microbiol Lett. 2008;282(2):238\u201340. https:\/\/doi.org\/10.1111\/j.1574-6968.2008.01126.x.","journal-title":"FEMS Microbiol Lett"},{"issue":"10","key":"2432_CR37","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1128\/AAC.48.10.4050-4053.2004","volume":"48","author":"H Mammeri","year":"2004","unstructured":"Mammeri H, Nazic H, Naas T, Poirel L, Leotard S, Nordmann P. AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins. Antimicrob Agents Chemother. 2004;48(10):4050\u20133. https:\/\/doi.org\/10.1128\/AAC.48.10.4050-4053.2004.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2432_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2217\/17460913.2.3.297","volume":"2","author":"P Nordmann","year":"2007","unstructured":"Nordmann P, Mammeri H. Extended-spectrum cephalosporinases: structure, detection and epidemiology. Future Microbiol. 2007;2(3):297\u2013307. https:\/\/doi.org\/10.2217\/17460913.2.3.297.","journal-title":"Future Microbiol"},{"key":"2432_CR39","doi-asserted-by":"publisher","unstructured":"Richards DM, Brogden RN, Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1985;29(2):105\u201361. https:\/\/doi.org\/10.2165\/00003495-198529020-00002.","DOI":"10.2165\/00003495-198529020-00002"},{"issue":"6149","key":"2432_CR40","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1126\/science.1236501","volume":"341","author":"BC Chung","year":"2013","unstructured":"Chung BC, Zhao J, Gillespie RA, Kwon DY, Guan Z, Hong J, et al. Crystal structure of MraY, an essential membrane enzyme for bacterial cell wall synthesis. Science. 2013;341(6149):1012\u20136. https:\/\/doi.org\/10.1126\/science.1236501.","journal-title":"Science"},{"issue":"7604","key":"2432_CR41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature17636","volume":"533","author":"BC Chung","year":"2016","unstructured":"Chung BC, Mashalidis EH, Tanino T, Kim M, Matsuda A, Hong J, et al. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis. Nature. 2016;533(7604):557\u201360. https:\/\/doi.org\/10.1038\/nature17636.","journal-title":"Nature"},{"issue":"34","key":"2432_CR42","doi-asserted-by":"publisher","first-page":"8919","DOI":"10.1021\/bi8006274","volume":"47","author":"B Al-Dabbagh","year":"2008","unstructured":"Al-Dabbagh B, Henry X, El Ghachi M, Auger G, Blanot D, Parquet C, et al. Active site mapping of MraY, a member of the polyprenyl-phosphate N-acetylhexosamine 1-phosphate transferase superfamily, catalyzing the first membrane step of peptidoglycan biosynthesis. Biochemistry. 2008;47(34):8919\u201328. https:\/\/doi.org\/10.1021\/bi8006274.","journal-title":"Biochemistry"},{"issue":"9","key":"2432_CR43","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1093\/jac\/dkz243","volume":"74","author":"M Castanheira","year":"2019","unstructured":"Castanheira M, Doyle TB, Smith CJ, Mendes RE, Sader HS. Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime\/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals. J Antimicrob Chemother. 2019;74(9):2588\u201395. https:\/\/doi.org\/10.1093\/jac\/dkz243.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"2432_CR44","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1128\/AAC.49.11.4763-4766.2005","volume":"49","author":"DJ Wolter","year":"2005","unstructured":"Wolter DJ, Hanson ND, Lister PD. AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump. Antimicrob Agents Chemother. 2005;49(11):4763\u20136. https:\/\/doi.org\/10.1128\/AAC.49.11.4763-4766.2005.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"2432_CR45","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1128\/AAC.45.7.1964-1971.2001","volume":"45","author":"K Okamoto","year":"2001","unstructured":"Okamoto K, Gotoh N, Nishino T. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay. Antimicrob Agents Chemother. 2001;45(7):1964\u201371. https:\/\/doi.org\/10.1128\/AAC.45.7.1964-1971.2001.","journal-title":"Antimicrob Agents Chemother"},{"key":"2432_CR46","doi-asserted-by":"publisher","unstructured":"Perez-Gallego M, Torrens G, Castillo-Vera J, Moya B, Zamorano L, Cabot G et al. Impact of AmpC derepression on fitness and virulence: the mechanism or the pathway? mBio. 2016;7(5). https:\/\/doi.org\/10.1128\/mBio.01783-16","DOI":"10.1128\/mBio.01783-16"},{"key":"2432_CR47","doi-asserted-by":"publisher","unstructured":"Aslan AT, Akova M. The role of Colistin in the era of New beta-lactam\/beta-lactamase inhibitor combinations. Antibiot (Basel). 2022;11(2). https:\/\/doi.org\/10.3390\/antibiotics11020277.","DOI":"10.3390\/antibiotics11020277"},{"issue":"1","key":"2432_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13613-023-01153-6","volume":"13","author":"F Barbier","year":"2023","unstructured":"Barbier F, Hraiech S, Kerneis S, Veluppillai N, Pajot O, Poissy J, et al. Rationale and evidence for the use of new beta-lactam\/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients. Ann Intensive Care. 2023;13(1):65. https:\/\/doi.org\/10.1186\/s13613-023-01153-6.","journal-title":"Ann Intensive Care"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02432-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-024-02432-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02432-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T19:12:40Z","timestamp":1743880360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-024-02432-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2432"],"URL":"https:\/\/doi.org\/10.1007\/s15010-024-02432-5","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained by the regional medical ethics committee (20201217-33).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No potential conflict of interest was reported by the author(s).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}